CPE Program - Metro East 3-17-2016

Thursday, March 17th, 2016
5:00 pm - 7:00 pm

New Drugs for Bad (Gram-Negative) Bugs

Faculty:

Julie H. McGinley, PharmD
PGY-1 Pharmacy Resident
HSHS St. Elizabeth’s Hospital
Belleville, IL
Adjunct Clinical Instructor
SIUE School of Pharmacy
Edwardsville, IL

Schedule:

5:00 pm - 7:00 pm

Registration:

Registration deadline is 9:00 am, March 15, 2016. There is no fee for ICHP members to attend this activity. Non-members who would like to earn CPE credit will be charged $20. There is no fee for non-members who do not want to earn CPE credit. Non-members who do not want to earn CPE credit should call the ICHP office at 815-227-9292 to register. When registering, there will be a place to enter your NABP e-profile ID#.

Location:

Anderson Hospital
Classroom #1
6800 IL-162
Maryville, IL 62062

Directions for Hospital: Enter through entrance labeled "Physician Office Building." Use elevators to go to the basement. Turn left and classrooms are immediately behind the elevators.

Learning Objectives:

At the conclusion of this application-based continuing pharmacy education activity, pharmacist participants should be able to:

1. Identify appropriate and inappropriate use of ceftazidime/avibactam and ceftolozane/tazobactam, given a patient case.
2. Correlate antibiotics and microbiology susceptibility reports based on gram negative patterns of resistance.
3. Compare and contrast the spectrum of activity of both ceftazidime/avibactam and ceftolozane/tazobactam and describe when each would be used clinically.
4. Apply current guideline recommendations to create an appropriate antimicrobial therapy regimen using ceftolozane/tazobactam and/or ceftazidime/avibactam when given a patient case.
5. Recommend appropriate antimicrobial dose adjustments when given patient specific parameters.

At the conclusion of this application-based continuing pharmacy education activity, pharmacy technician participants should be able to:

1. Assign the generic name to the brand name for ceftazidime/avibactam and ceftolozane/tazobactam and various other multi-drug antibiotics.
2. Recognize a potential duplication of therapy, with regard to antibiotics, given a patient's medication list.
3. Formulate the appropriate method for reconstituting and diluting ceftolozane/tazobactam and ceftazidime/avibactam for administration.
4. Describe the appropriate storage conditions for reconstituted and diluted ceftazidime/avibactam and ceftolozane/tazobactam and recommend appropriate expiration dates for room temperature vs. refrigerated.

Accreditation:

1.0 Contact Hour (0.1 CEU)
The Illinois Council of Health System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity provides 1 hour (0.1 CEU) of application-based continuing pharmacy education credit. ACPE UAN: 0121-0000-16-018-L01-P & 0121-0000-16-018-L01-T Type of Activity: Application-based

Attendees must complete a program evaluation online at www.CESally.com.

Target Audience: This application-based activity was developed for Health-System Pharmacists and Pharmacy Technicians.

PTCB now requires CPhTs to earn only pharmacy technician-specific (‘T-specific’) credit to qualify for recertification.
In addition, PTCB will reduce the number of allowable CPE hours earned through in-service training from 10 to 5. Please advise all pharmacy technicians at your site of this change.

CPE Monitor: When registering for this program, you will be asked to provide your NABP e-Profile ID # and Birthday. Visit www.ichpnet.org/cpemonitor/ for information about CPE Monitor and how to obtain your NABP ID.